Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis
Article in Frontiers in Endocrinology (December 2023)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
Article in The Breast (November 2023)
Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study
Article in Translational Cancer Research (October 2023)